Strides Pharma Science Ltd.

785.70 +5.80 ▲0.7%

29 February 2024, 04:01:00 PM
Volume: 9,460

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.strides.com
Market Cap 7,238.02 Cr.
Enterprise Value(EV) 9,630.55 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -10.70 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.63 Trailing Twelve Months Ending 2023-12
Book Value / Share 236.54 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.33 Calculated using Price: 787.60
Dividend Yield 0.19 Period Ending 2023-03
No. of Shares Subscribed 9.19 Cr. 91,899,714 Shares
FaceValue 10
About Strides Pharma Science Ltd.
The company's core competence is in the development and manufacture of wide range of niche and technically complex pharmaceutical products. The company is also among the world's largest soft gelatin capsule manufacturers.

Strides Pharma Science Ltd. Delivery

Delivered Qty
Traded Qty

Strides Pharma Science Ltd. Performance

1 Day
+0.74%
1 Week
-5.29%
1 Month
+14.58%
3 Month
+58.38%
6 Month
+79.28%
1 Year
+163.83%
2 Year
+145.61%
5 Year
+86.85%
10 Year
+123.85%

Strides Pharma Science Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0.09 6.22 10.37 2.86 3.5 1.68 9.21 -18.49 -10.15
Return on Capital Employed (%) 10.92 7.98 8.32 4.83 2.61 4.06 9.08 -9.49 -0.49
Return on Assets (%) 0.04 2.4 3.63 1.02 1.24 0.63 3.82 -6.99 -3.52

Strides Pharma Science Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 1,145 2,658 2,749 2,464 2,649 2,527 2,777 2,359 2,212 2,054
Non Curr. Liab. 286 2,760 2,049 2,067 2,343 814 1,264 966 1,210 916
Curr. Liab. 1,020 1,892 3,104 1,896 2,662 2,545 2,738 3,412 2,990 3,138
Minority Int. 19 50 134 155 153 67 37 24 -39 -60
Equity & Liab. 2,469 7,360 8,035 6,585 7,807 5,953 6,817 6,761 6,373 6,047
Non Curr. Assets 1,040 3,845 4,243 4,101 4,758 3,581 4,000 3,399 3,130 2,658
Curr. Assets 1,429 3,515 3,792 2,447 3,049 2,371 2,817 3,362 3,135 3,389
Misc. Exp. not W/O
Total Assets 2,469 7,360 8,035 6,585 7,807 5,953 6,817 6,761 6,373 6,047

Strides Pharma Science Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 1,196 2,862 2,755 2,845 2,178 2,752 3,316 3,070 3,688 3,953
Other Income 39 92 161 88 41 53 59 133 135 80
Total Income 1,234 2,954 2,917 2,933 2,219 2,805 3,375 3,204 3,824 4,034
Total Expenditure -967 -2,448 -2,228 -2,443 -1,936 -2,236 -2,689 -3,092 -3,303 -3,284
PBIDT 267 506 688 491 283 569 686 112 521 749
Interest -47 -168 -183 -196 -79 -156 -150 -177 -261 -315
Depreciation -64 -131 -126 -154 -117 -174 -206 -233 -243 -232
Taxation -148 -42 -63 -6 27 -11 -32 178 55 -19
Exceptional Items -7 -41 -36 -44 22 -78 43 -244 -17 -188
PAT 1 118 280 74 89 43 244 -474 -231 -5
Minority Interest 1 14 -46 -20 -5 6 11 14 10 20
Share Associate -168
Other Related Items
Consolidated Net Profit 845 109 400 665 325 36 268 -460 -203 -98
Adjusted EPS 142 12 45 74 36 4 30 -51 -22 -11

Strides Pharma Science Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -272 83 73 288 187 60 205 481 -258 44
Cash Fr. Inv. 4,077 52 -2,225 -687 583 -148 1,306 -521 -119 302
Cash Fr. Finan. -3,319 -421 2,944 338 -1,016 194 -1,709 -16 421 -214
Net Change 487 -286 792 -60 -246 106 -199 -55 45 133
Cash & Cash Eqvt 586 298 1,111 515 256 366 182 126 171 304

Strides Pharma Science Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 29.60 30.60 30.37 31.07 30.89 28.27 28.07 27.78 27.39
Public 70.40 69.40 69.63 68.93 69.11 71.73 71.93 72.22 72.61
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 37.84 56.67 62.20 69.42 69.44 81.80 80.80 67.40 69.17

Strides Pharma Science Ltd. Announcements

Tue, 20 Feb 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issuance of LOC - Dipak
Tue, 20 Feb 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issuance of LOC - Geeta K Doshi
Mon, 05 Feb 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Earnings call transcript

Strides Pharma Science Ltd. Technical Scans

Thu, 29 Feb 2024
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Below Last Week Low Close Below Last Week Low
Close Above Last Month High Close Above Last Month High
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months

Strides Pharma Science Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 378,183.18 1,577.95 +0.3%
Cipla Ltd. 119,792.84 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. 107,100.71 6,424.25 -0.1%
Zydus Lifesciences Ltd. 95,405.30 941.90 +1.0%
Divi's Laboratories Ltd. 92,624.64 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. 90,256.63 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. 87,793.47 6,105.90 -3.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 32.31 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.49 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 66.98 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.41 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 111.23 6,105.90 -3.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.06 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 4.63 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.99 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.91 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.11 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.62 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.00 6,105.90 -3.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,105.90 -3.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,105.90 -3.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,105.90 -3.9%

Strides Pharma Science Ltd. FAQ's

What is Strides Pharma Scien share price?

Can I buy Strides Pharma Scien shares now?

What is the Dividend Yield of Strides Pharma Scien?

What is the Market Cap of Strides Pharma Scien?

What are the key metrics to analyse Strides Pharma Scien?

What is the 52 Week High and Low of Strides Pharma Scien?

What is the trend of Strides Pharma Scien share price?